Operations & Management
Partnership on SDOH Bolsters Rheumatoid Arthritis Outcomes
A partnership between specialty pharmacy accelerator Shields Health Solutions and Bronson Healthcare in Michigan improved health outcomes for people with rheumatoid arthritis facing food insecurity and other challenges related to social determinants of health.
AUGUST 20, 2025
Accreditation Leaders Cite Network Access, Other Key Benefits
Specialty pharmacy accreditation rewards excellence that goes beyond meeting licensure requirements, according to leaders of accrediting organizations who spoke at Asembia’s AXS25 Summit.
AUGUST 18, 2025
Managed Care Pharmacies: Prepare for Disruption
A new report outlines how the emergence of artificial intelligence, growth of therapeutics such as cell and gene therapies, and significant regulatory changes are likely to disrupt the managed care industry.
AUGUST 11, 2025
FMT May Boost Immunotherapy Effectiveness
Fecal microbiota transplantation may enhance the effectiveness of immunotherapies by reducing gut dysbiosis, according to a presentation at the 2025 ASCO Annual Meeting.
JULY 24, 2025
New Biosimilars Metric Confirms Switching Efficacy
Most patients who were switched from Humira to an interchangeable biosimilar experienced clinical success, with most remaining on a biosimilar three months after conversion, according to a study conducted at Brown University Health.
JULY 23, 2025
Data Shows Preference for CAB-LA PrEP Without Straining Clinics
Two studies presented at IAS 2025 demonstrated the acceptability and feasibility of using Apretude for PrEP in broad U.S. populations, including MSM, transgender men and Black women.
JULY 22, 2025
Why are Fewer Pharmacy Residents Completing Their Training?
More than half of pharmacy directors polled in a new survey said that at least one of their residents failed to complete their PGY-1 programs, and about one-quarter noted that many of the residents who do graduate are electing not to pursue a PGY-2 position, according to data presented at the ASHP Pharmacy Futures 2025 meeting.
JULY 18, 2025
IDNs Will Use AI, Other Tools To Improve Cell and Gene Therapies
Integrated delivery networks will be critical in improving access to cell and gene therapies in the coming years, with artificial intelligence and data-mining of electronic health records.
JUNE 16, 2025
Tariffs Putting Heat on Temperature-Controlled Supply Chain
The Trump administration’s tariffs on imported goods won’t hit just the pharmaceutical industry through higher costs for imported generic drugs and active pharmaceutical ingredients.
JUNE 14, 2025
Tariffs and Strong Market Growth on Tap At Doug Long’s AXS25 Summit Swan Song
The U.S. pharma market grew in income by 10% last year alone, with almost 80% of that increase coming from greater volume rather than price adjustments or new market entrants.
JUNE 13, 2025
Risk Management Not Just Clinical for CAR-Ts: High Cost Also a Target
With more CAR-T therapies being approved or receiving expanded indications, balancing access, cost and risk management is crucial but very challenging, experts said at the AMCP 2025 annual meeting.
MAY 30, 2025
Survey: Managing Specialty Drug Costs a Rising Concern Among Employers, Health Plans
Managing overall specialty drug costs and total cost of care are the top goals in specialty management expressed by 84% of employers and health plans, according to results of the 2025 Trends in Specialty Drug Benefits Report.
MAY 28, 2025
